Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.60 |
| ▸ | NPC1 | O15118 | 4/20 | 0.60 |
| ▸ | KIF11 | P52732 | 3/20 | 0.47 |
| ▸ | XDH | P47989 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | TNF | P01375 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12311644 | 0.98 | RAB9A (0.58) | RAB9ANPC1KIF11XDHTP53 | |
| SCHEMBL19193784 | 0.96 | RAB9A (0.60) | RAB9ANPC1KIF11XDHTP53 | |
| SCHEMBL25845622 | 0.93 | RAB9A (0.53) | RAB9ANPC1KIF11XDHTP53 | |
| SCHEMBL6680571 | 0.89 | NPC1 (0.72) | RAB9ANPC1KIF11XDHTP53 | |
| SCHEMBL17968223 | 0.89 | RAB9A (0.53) | RAB9ANPC1KIF11XDHTP53 | |
| SCHEMBL23624571 | 0.88 | NPC1 (0.60) | RAB9ANPC1KIF11XDHTP53 | |
| SCHEMBL24285466 | 0.87 | NPC1 (0.51) | RAB9ANPC1KIF11XDHTP53 | |
| SCHEMBL4125159 | 0.87 | NPC1 (0.69) | RAB9ANPC1KIF11XDHTP53 | |
| SCHEMBL13871684 | 0.87 | NPC1 (0.69) | RAB9ANPC1KIF11XDHTP53 | |
| SCHEMBL30477729 | 0.87 | KIF11 (0.64) | RAB9ANPC1KIF11XDHTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12520720-B2 | Heterocyclic compound and organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-01-06 | — | — | US | disclosed |
| EP-3617202-B1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-11-05 | — | — | EP | disclosed |
| CN-110862378-B | Heterocyclic compound and organic light-emitting device | 三星电子株式会社 | 2024-11-15 | — | — | CN | disclosed |
| CN-115894449-B | Spiro organic compound and application thereof in organic photoelectric device | 广州追光科技有限公司 | 2024-07-02 | — | — | CN | disclosed |
| US-12022732-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2024-06-25 | — | — | US | disclosed |
| EP-3844245-B1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2024-06-05 | — | — | EP | disclosed |
| US-20230403927-A1 | AROMATIC COMPOUNDS | UDC IRELAND LTD (IE) | 2023-12-14 | — | — | US | disclosed |
| US-20230403927-A1 | AROMATIC COMPOUNDS | UDC IRELAND LTD (IE) | 2023-12-14 | — | — | US | disclosed |
| EP-3313855-B1 | METAL COMPLEX AND ORGANIC LIGHT-EMITTING DEVICE | CAMBRIDGE DISPLAY TECH LTD (GB) | 2023-10-25 | — | — | EP | disclosed |
| US-11800787-B2 | Metal complexes | UDC IRELAND LIMITED (IE) | 2023-10-24 | — | — | US | disclosed |
| US-6710177-B2 | REACTING A CYANURIC HALIDE WITH BENZENE COMPOUND | CYTEC TECHNOLOGY CORP. | 2004-03-23 | — | — | US | disclosed |
| US-6509399-B2 | Radiation resistance; absorber | CYTEC TECHNOLOGY CORP | 2003-01-21 | — | — | US | disclosed |
| US-6486316-B1 | Process for making triazine UV absorbers using Lewis acids and reaction promoters | CYTEC TECHNOLOGY CORP. | 2002-11-26 | — | — | US | disclosed |
| US-20020013463-A1 | Process for making triazine UV absorbers using Lewis acids and reaction promoters | CYTEC INDUSTRIES CORP. | 2002-01-31 | — | — | US | disclosed |
| US-20020013462-A1 | Non-yellowing part-tertiary-alkyl phenyl substituted triazine and pyrimidine ultraviolet light absorbers | CYTEC INDUSTRIES CORP. | 2002-01-31 | — | — | US | disclosed |
| US-20010031867-A1 | Non-yellowing para-tertiary-alkyl phenyl substituted triazineand pyrimidine ultraviolet light absorbers | CYTEC INDUSTRIES CORP. | 2001-10-18 | — | — | US | disclosed |
| EP-1131305-A1 | PROCESS FOR PREPARING TRIAZINES USING A COMBINATION OF LEWIS ACIDS WITH REACTION PROMOTERS | CYTEC TECHNOLOGY CORP. (US) | 2001-09-12 | — | — | EP | disclosed |
| US-20010020094-A1 | Process for making triazine UV absorbers using lewis acids and reaction promoters | CYTEC TECHNOLOGIES CORP. | 2001-09-06 | — | — | US | disclosed |
| US-6239276-B1 | STABILIZER | CYTEC TECHNOLOGY CORPORATION | 2001-05-29 | — | — | US | disclosed |
| WO-2000029392-A1 | PROCESS FOR PREPARING TRIAZINES USING A COMBINATION OF LEWIS ACIDS AND REACTION PROMOTERS | CYTEC TECHNOLOGY CORP. (US) | 2000-05-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031867-A1 | Non-yellowing para-tertiary-alkyl phenyl substituted triazineand pyrimidine ultraviolet light absorbers | TERB1, RAD52, ERCC4 | RAB9A 4124/4885NPC1 3899/4885KIF11 3789/4885 |
| US-20230403927-A1 | AROMATIC COMPOUNDS | TYR, CTCF, MITF | RAB9A 2503/4885NPC1 3191/4885KIF11 2369/4885 |
| US-12022732-B2 | Materials for organic electroluminescent devices | MT-CO3, MT-ND3, MT-ND5 | RAB9A 4079/4885NPC1 4526/4885KIF11 1869/4885 |
| US-20020013463-A1 | Process for making triazine UV absorbers using Lewis acids and reaction promoters | TYR, TDO2, CYP4Z1 | RAB9A 3193/4885NPC1 2663/4885KIF11 4276/4885 |
| US-11800787-B2 | Metal complexes | AP1M1, SOD1, AP3M1 | RAB9A 1927/4885NPC1 3855/4885KIF11 1873/4885 |
| US-20010020094-A1 | Process for making triazine UV absorbers using lewis acids and reaction promoters | TYR, TDO2, CYP4Z1 | RAB9A 3193/4885NPC1 2663/4885KIF11 4276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.